Subscribe To Our Free Newsletter |
Lupin receives USFDA approval for Travoprost Ophthalmic Solution USP
Travoprost Ophthalmic Solution USP, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.